Taysha Gene Therapies

TSHANASDAQ
$2.15
-0.01-0.46%
At Close: -
$2.17
0.020.93%
After Hours: 2:37 PM EDT
15 minutes delayed

Taysha Gene Therapies (NASDAQ:TSHA) Stock Quotes, Forecast and News Summary

Taysha Gene Therapies Stock (NASDAQ: TSHA) stock price, news, charts, stock research, profile.

Open$2.24
Close$2.15
Volume / Avg.810.08K / 2.72M
Day Range2.15 - 2.29
52 Wk Range0.61 - 4.32
Market Cap$436.99M
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
35
Short Interest
9.7%
Days to Cover6.54
-%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trends and Forecast
4
Apr
2
May
2
Jun
1
Jul
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
3.7
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell
About Taysha Gene Therapies Inc
Sector
Health Care
Industry
Biotechnology
Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disea...
Show More

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
TSHA
KALV

FAQ

Q

How do I buy Taysha Gene Therapies (TSHA) stock?

A

You can purchase shares of Taysha Gene Therapies (NASDAQ:TSHA) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Taysha Gene Therapies (TSHA) competitors?

Q

What is the target price for Taysha Gene Therapies (TSHA) stock?

A

There is no analysis for Taysha Gene Therapies.

Q

What is the forecast for Taysha Gene Therapies (TSHA) stock?

A

Taysha Gene Therapies has a consensus price target of $8.61.

Q

Current stock price for Taysha Gene Therapies (TSHA)?

A

The stock price for Taysha Gene Therapies (NASDAQ: TSHA) is $2.17 last updated Today at July 3, 2024 at 2:37 PM EDT.

Q

Does Taysha Gene Therapies (TSHA) pay a dividend?

A

There are no upcoming dividends for Taysha Gene Therapies.

Q

When is Taysha Gene Therapies (NASDAQ:TSHA) reporting earnings?

A

Taysha Gene Therapies’s Q2 earnings are confirmed for Monday, August 12, 2024.

Q

Is Taysha Gene Therapies (TSHA) going to split?

A

There is no upcoming split for Taysha Gene Therapies.

Q

What sector and industry does Taysha Gene Therapies (TSHA) operate in?

A

Taysha Gene Therapies is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch